McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing

McKesson (MCK) recently closed at $801.67, outperforming the S&P 500 with a 1.1% daily gain and a 7.66% monthly increase, leading its Medical sector. The company is set to report earnings on November 5, 2025, with consensus estimates projecting a 26.17% EPS increase to $8.92 and an 11.76% revenue rise to $104.66 billion for the quarter, alongside robust full-year growth forecasts. Despite a slight 0.56% decrease in the 30-day Zacks Consensus EPS estimate, MCK holds a Zacks Rank of #3 (Hold) and trades at a premium Forward P/E of 20.84 compared to its industry's 13.51, though its PEG ratio of 1.43 is below the industry average of 1.64.

Analysis

McKesson (MCK) has demonstrated robust market performance, closing at $801.67 with a daily gain of 1.1%, outpacing the S&P 500's 0.79%. Over the past month, the stock surged 7.66%, significantly leading the Medical sector's 3.99% gain and the S&P 500's 1.27%. This strong momentum precedes its upcoming earnings report on November 5, 2025, where consensus estimates project a 26.17% year-over-year EPS increase to $8.92 and an 11.76% revenue escalation to $104.66 billion.

The company's positive outlook extends to its full fiscal year, with Zacks Consensus Estimates forecasting EPS of $38.05, a 15.13% increase, and revenue of $409.17 billion, up 13.96% from the prior year. Despite these strong growth projections, the Zacks Consensus EPS estimate has seen a slight 0.56% decrease over the last 30 days, contributing to its current Zacks Rank of #3 (Hold). This minor revision suggests some evolving short-term business trends, though overall sentiment remains optimistic.

Valuation metrics indicate MCK trades at a Forward P/E of 20.84, representing a premium compared to the Medical - Dental Supplies industry average of 13.51. However, its PEG ratio of 1.43 is below the industry average of 1.64, suggesting a more favorable valuation when accounting for expected earnings growth. The Medical - Dental Supplies industry, with a Zacks Industry Rank of 98 (top 40%), historically outperforms lower-ranked industries, providing a supportive sector backdrop for MCK.

Key Decisions for Investors

• Monitor the upcoming Q3 earnings report on November 5, 2025, for confirmation of strong EPS and revenue growth forecasts, as these will be key drivers for continued stock performance.
• Evaluate MCK's valuation, noting its premium Forward P/E relative to the industry but a more attractive PEG ratio, suggesting growth potential may justify current pricing.
• Consider the slight 0.56% decrease in the 30-day Zacks Consensus EPS estimate as a potential signal for short-term trend adjustments, despite the overall positive outlook and strong sector performance.